3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-thiazolidine hydrobromide(2:5)

CAS: 906093-29-6

Ref. 3D-FM61598

Información del producto

• Nombre: 3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]-thiazolidine hydrobromide(2:5)
• Sinónimos: Teneligliptin Hydrobromide

Descripción

Canagliflozin is a pharmaceutical drug that is used to treat type 2 diabetes. It is an oral medication that works by blocking the absorption of glucose in the intestine, which lowers blood sugar levels and improves insulin sensitivity. Canagliflozin has been shown to have a number of effects on metabolism, including increased bile acid production and decreased fat absorption. This drug also has a number of side effects, including diarrhea, nausea, and vomiting. Canagliflozin is used in combination with metformin or insulin for the treatment of type 2 diabetes. The drug's most common side effect is diarrhea, which can be managed by eating more fiber-rich foods and drinking plenty of fluids.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 1,257.72 g/mol
• Fórmula: (C₂₂H₃₀N₆OS)₂•(HBr)₅
• Pureza: Min. 95%
• Color/Forma: White/Off-White Solid